支气管切除症恶化增加了不良脏结果的风险 - - 来自一项大范围的对象群研究的结果
Wang Chun Kwok1, Chung Ki Tsui1, Leung Sze Him Isaac2
1Division of Respiratory Medicine and Critical Care Medicine, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
The clinical respiratory journal
|January 11, 2025
概括
支气管切除症恶化 (BE) 显著增加病进展和急性损伤 (AKI) 的风险. 与没有恶化的患者相比,经历BE的患者面临较差的结局.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 支气管切除症恶化 (BE) 与心血管问题有关,但其对脏的影响尚不清楚.
- 了解BE对脏的后果对于患者管理至关重要.
研究的目的:
- 调查支气管切除症恶化与不良结局之间的关联.
- 确定BE是否是进展和急性损伤 (AKI) 的独立风险因素.
主要方法:
- 在香港 (1993-2017) 进行了一项全境回顾性队列研究.
- 支气管切除症患者被分为"加剧者"或"非加剧者".
- 对脏不良结果进行了比较,包括脏进展,AKI和eGFR下降,用于分析的是倾向性得分匹配.
主要成果:
- 恶化剂显示进展 (aOR 1.27) 和AKI (aOR 1.99) 的风险明显更高.
- 恶化体验者在估计的淋巴细胞过率 (eGFR) 中出现了更快的下降.
- 每年发生的BE事件数量与进展和AKI风险增加有关.
结论:
- 脏进展和AKI在支气管切除症患者中很常见.
- 支气管切除症恶化是不良结局的独立风险因素.
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Renal Drug Excretion: Tubular Reabsorption
89
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
89
Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
89
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
89
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


